Skip to main content

Advertisement

SpringerLink
Log in

Do nutraceutics play a role in the prevention and treatment of colorectal cancer?

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Colorectal cancer is the third most common cancer worldwide with a 5-year survival of 50%. Current chemotherapeutic regimens used for advanced colorectal cancer provide an average survival of approximately 20 months. Non-toxic agents such as nutraceutics and supplements have been shown to aid in the prevention and adjuvant treatment of colorectal cancer. This article will discuss the epidemiology, progression, prevention, treatment, and recurrence of colorectal cancer and the role of nutraceutics and supplements in the treatment process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parkin, D. M., Bray, F., Ferlay, J., et al. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74–108.

    Article  Google Scholar 

  2. Jemal, A., Siegel, R., Ward, E., et al. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225–249.

    Article  Google Scholar 

  3. Rex, D. K., Johnson, D. A., Anderson, J. C., et al. (2009). American college of gastroenterology guidelines for colorectal cancer screening 2008. The American Journal of Gastroenterology, 104, 739–750.

    Article  PubMed  Google Scholar 

  4. Winawer, S., Fletcher, R., Rex, D., et al. (2003). Colorectal cancer screening and surveillance: clinical guidelines and rationale—Update based on new evidence. Gastroenterology, 124, 544–560.

    Article  PubMed  Google Scholar 

  5. Patel, B. B., Yu, Y., Du, J., et al. (2009). Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer. Biochemical and Biophysical Research Communications, 378, 344–347.

    Article  CAS  PubMed  Google Scholar 

  6. Davila, R. E., Rajan, E., Baron, T. H., et al. (2006). ASGE guideline: colorectal cancer screening and surveillance. Gastrointestinal Endoscopy, 63, 546–557.

    Article  PubMed  Google Scholar 

  7. Robbins, D. H., & Itzkowitz, S. H. (2002). The molecular and genetic basis of colon cancer. The Medical Clinics of North America, 86, 1467–1495.

    Article  CAS  PubMed  Google Scholar 

  8. Kanwar, S. S., Nautiyal, J., & Majumdar, A. P. (2010). EGFR(s) inhibitors in the treatment of gastro-intestinal cancers: what’s new? Current Drug Targets, 11, 682–698.

    Article  CAS  PubMed  Google Scholar 

  9. Pino, M. S., & Chung, D. C. (2010). The chromosomal instability pathway in colon cancer. Gastroenterology, 138, 2059–2072.

    Article  CAS  PubMed  Google Scholar 

  10. Salama, P., & Platell, C. (2009). Colorectal cancer stem cells. ANZ Journal of Surgery, 79, 697–702.

    Article  PubMed  Google Scholar 

  11. Friedlich, M. S. S. (2002). Prevention of colorectal cancer. Canadian Journal of CME, 14, 112–119.

    Google Scholar 

  12. Chan, A. T., & Giovannucci, E. L. (2010). Primary prevention of colorectal cancer. Gastroenterology, 138, 2029–2043.

    Article  CAS  PubMed  Google Scholar 

  13. Nautiyal, J., Kanwar, S. S., & Majumdar, A. P. (2010). EGFR(s) in saging and carcinogenesis of the gastrointestinal tract. Current Protein & Peptide Science, 11, 436–450.

    Article  CAS  Google Scholar 

  14. Winawer, S. J. (2007). Colorectal cancer screening. Best Practice & Research. Clinical Gastroenterology, 21, 1031–1048.

    Article  Google Scholar 

  15. Sleisenger, M. H. (2006). Sleisenger & Fordtran’s gastrointestinal and liver disease Pathophysiology, diagnosis, management. St. Louis, Mo: W.B. Saunders.

    Google Scholar 

  16. Yu, Y., Kanwar, S. S., Patel, B. B., et al. (2009). Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX. Transl Oncol, 2, 321–328.

    PubMed  Google Scholar 

  17. Kalra, E. (2003). Nutraceutical-definition and introduction. The AAPS Journal, 5, 27–28.

    Google Scholar 

  18. Majumdar, A. P., Kodali, U., & Jaszewski, R. (2004). Chemopreventive role of folic acid in colorectal cancer. Frontiers in Bioscience, 9, 2725–2732.

    Article  CAS  PubMed  Google Scholar 

  19. Laanpere, M., Altmae, S., Stavreus-Evers, A., et al. (2010). Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability. Nutrition Reviews, 68, 99–113.

    Article  PubMed  Google Scholar 

  20. Vecchia, C. L., Negri, E., Pelucchi, C., et al. (2002). Dietary folate and colorectal cancer. International Journal of Cancer, 102, 545–547.

    Article  Google Scholar 

  21. Lashner, B. A., Heidenreich, P. A., Su, G. L., Kane, S. V., & Hanauer, S. B. (1989). Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis: A case-control study (97th ed.). New York: Elsevier. ETATS-UNIS.

    Google Scholar 

  22. Kim, Y. I. (2003). Role of folate in colon cancer development and progression. Journal of Nutrition, 133(11 Suppl 1), 3731S–3739S.

    CAS  PubMed  Google Scholar 

  23. Sanjoaquin, M. A., Allen, N., Couto, E., et al. (2005). Folate intake and colorectal cancer risk: a meta-analytical approach. International Journal of Cancer, 113, 825–828.

    Article  CAS  Google Scholar 

  24. Jaszewski, R., Misra, S., Tobi, M., et al. (2008). Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World Journal of Gastroenterology, 14, 4492–4498.

    Article  CAS  PubMed  Google Scholar 

  25. Jaszewski, R., Khan, A., Sarkar, F. H., et al. (1999). Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines. The American Journal of Physiology, 277, C1142–C1148.

    CAS  PubMed  Google Scholar 

  26. Kim, Y. I. (2007). Folate and colorectal cancer: an evidence-based critical review. Molecular Nutrition & Food Research, 51, 267–292.

    Article  CAS  Google Scholar 

  27. Van der Meer, R., & De Vries, H. T. (1985). Differential binding of glycine- and taurine-conjugated bile acids to insoluble calcium phosphate. The Biochemical Journal, 229, 265–268.

    PubMed  Google Scholar 

  28. Pence, B. C., & Buddingh, F. (1988). Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis, 9, 187–190.

    Article  CAS  PubMed  Google Scholar 

  29. Baron, J. A., Beach, M., Mandel, J. S., et al. (1999). Calcium supplements for the prevention of colorectal adenomas. Calcium polyp prevention study group. The New England Journal of Medicine, 340, 101–107.

    Article  CAS  PubMed  Google Scholar 

  30. Newmark, H. L., Wargovich, M. J., & Bruce, W. R. (1984). Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. Journal of the National Cancer Institute, 72, 1323–1325.

    CAS  PubMed  Google Scholar 

  31. Lipkin, M., & Newmark, H. (1985). Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. The New England Journal of Medicine, 313, 1381–1384.

    Article  CAS  PubMed  Google Scholar 

  32. Garland, C. F., & Garland, F. C. (2006). Do sunlight and vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology, 35, 217–220.

    Article  PubMed  Google Scholar 

  33. Ng, K., Meyerhardt, J. A., Wu, K., et al. (2008). Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. Journal of Clinical Oncology, 26, 2984–2991.

    Article  CAS  PubMed  Google Scholar 

  34. Chakrabarty, S., Wang, H., Canaff, L., et al. (2005). Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1, 25-dihydroxyvitamin D(3). Cancer Research, 65, 493–498.

    CAS  PubMed  Google Scholar 

  35. Wang, X. T., Nagaba, Y., Cross, H. S., et al. (2000). The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. The American Journal of Pathology, 157, 1549–1562.

    CAS  PubMed  Google Scholar 

  36. Peterlik, M., Grant, W. B., & Cross, H. S. (2009). Calcium, vitamin D and cancer. Anticancer Research, 29, 3687–3698.

    CAS  PubMed  Google Scholar 

  37. Lieberman, D. A., Prindiville, S., Weiss, D. G., et al. (2003). Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA, 290, 2959–2967.

    Article  PubMed  Google Scholar 

  38. Diaz, G. D., Paraskeva, C., Thomas, M. G., et al. (2000). Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Research, 60, 2304–2312.

    CAS  PubMed  Google Scholar 

  39. Taghizadeh, F., Tang, M. J., & Tai, I. T. (2007). Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy. Molecular Cancer Therapeutics, 6, 309–317.

    Article  CAS  PubMed  Google Scholar 

  40. Martinez, M. E., & Willett, W. C. (1998). Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiology, Biomarkers & Prevention, 7, 163–168.

    CAS  Google Scholar 

  41. Shaukat, A., Scouras, N., & Schunemann, H. J. (2005). Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials. The American Journal of Gastroenterology, 100, 390–394.

    Article  CAS  PubMed  Google Scholar 

  42. Hanif, R., Qiao, L., Shiff, S. J., et al. (1997). Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. The Journal of Laboratory and Clinical Medicine, 130, 576–584.

    Article  CAS  PubMed  Google Scholar 

  43. Gamelin, L., Boisdron-Celle, M., Delva, R., et al. (2004). Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer. Clinical Cancer Research, 10, 4055–4061.

    Article  CAS  PubMed  Google Scholar 

  44. Kurniali, P. C., Luo, L. G., & Weitberg, A. B. (2010). Role of calcium/magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients. Oncology (Williston Park), 24, 289–292.

    Google Scholar 

  45. Perkins, S., Verschoyle, R. D., Hill, K., et al. (2002). Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiology, Biomarkers & Prevention, 11, 535–540.

    CAS  Google Scholar 

  46. Barnes, C. J., & Lee, M. (1998). Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. Gastroenterology, 114, 873–877.

    Article  CAS  PubMed  Google Scholar 

  47. Aggarwal, B. B., Ichikawa, H., Garodia, P., et al. (2006). From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets, 10, 87–118.

    Article  CAS  PubMed  Google Scholar 

  48. Cantorna, M. T., Munsick, C., Bemiss, C., et al. (2000). 1, 25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. The Journal of Nutrition, 130, 2648–2652.

    CAS  PubMed  Google Scholar 

  49. Fedirko, V., Bostick, R. M., Flanders, W. D., et al. (2009). Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiology, Biomarkers & Prevention, 18, 2933–2941.

    Article  CAS  Google Scholar 

  50. Newmark, H. L., Yang, K., Kurihara, N., et al. (2009). Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis, 30, 88–92.

    Article  CAS  PubMed  Google Scholar 

  51. Hartman, T. J., Albert, P. S., Snyder, K., et al. (2005). The association of calcium and vitamin D with risk of colorectal adenomas. The Journal of Nutrition, 135, 252–259.

    CAS  PubMed  Google Scholar 

  52. Villegas, I., Sanchez-Fidalgo, S., & Arcon de la Lastra, C. (2008). New mechanisms and therapeutic potential of curcumin for colorectal cancer. Molecular Nutrition & Food Research, 52, 1040–1061.

    Article  CAS  Google Scholar 

  53. Grant, K. L. P., & Schneider, C. D. M. D. (2000). Turmeric. [Miscellaneous Article]. American Journal of Health-System Pharmacy, 57, 1121–1122.

    CAS  PubMed  Google Scholar 

  54. Patel, B. B., & Majumdar, A. P. N. (2009). Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. Nutrition and Cancer, 61, 842–846.

    Article  CAS  PubMed  Google Scholar 

  55. Kawamori, T., Lubet, R., Steele, V. E., et al. (1999). Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Research, 59, 597–601.

    CAS  PubMed  Google Scholar 

  56. Sharma, R. A., Euden, S. A., Platton, S. L., et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clinical Cancer Research, 10, 6847–6854.

    Article  CAS  PubMed  Google Scholar 

  57. Patel, B. B., Sengupta, R., Qazi, S., et al. (2008). Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. International Journal of Cancer, 122, 267–273.

    Article  CAS  Google Scholar 

  58. Kunnumakkara, A. B., Diagaradjane, P., Anand, P., et al. (2009). Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. International Journal of Cancer, 125, 2187–2197.

    Article  CAS  Google Scholar 

  59. Adachi, Y., Lee, C. T., Coffee, K., et al. (2002). Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology, 123, 1191–1204.

    Article  CAS  PubMed  Google Scholar 

  60. Hakam, A., Yeatman, T. J., Lu, L., et al. (1999). Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Human Pathology, 30, 1128–1133.

    Article  CAS  PubMed  Google Scholar 

  61. Wang, J. C., & Dick, J. E. (2005). Cancer stem cells: lessons from leukemia. Trends in Cell Biology, 15, 494–501.

    Article  CAS  PubMed  Google Scholar 

  62. Dick, J. E. (2008). Stem cell concepts renew cancer research. Blood, 112, 4793–4807.

    Article  CAS  PubMed  Google Scholar 

  63. Patel, B. B., Gupta, D., Elliott, A. A., et al. (2010). Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Research, 30, 319–325.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Veterans Affairs Medical Center, Wayne State University, Detroit, MI, 48201, USA

    Adhip P. N. Majumdar

  2. Department of Internal Medicine, Wayne State University, Detroit, MI, 48201, USA

    Brian Markle, Elizabeth J. May & Adhip P. N. Majumdar

  3. Karmanos Cancer Institute, Wayne State University, Detroit, MI, 48201, USA

    Adhip P. N. Majumdar

  4. VA Medical Center, Research Service, 4646 John R; Room-B4238, Detroit, MI, 48201, USA

    Adhip P. N. Majumdar

Authors
  1. Brian Markle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth J. May
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adhip P. N. Majumdar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adhip P. N. Majumdar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markle, B., May, E.J. & Majumdar, A.P.N. Do nutraceutics play a role in the prevention and treatment of colorectal cancer?. Cancer Metastasis Rev 29, 395–404 (2010). https://doi.org/10.1007/s10555-010-9234-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-010-9234-3

Keywords

Search

Navigation